Edition:
India

Insider Trading: Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

1.84USD
15 Nov 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.84
Open
$1.85
Day's High
$1.86
Day's Low
$1.83
Volume
21,789
Avg. Vol
155,418
52-wk High
$9.19
52-wk Low
$1.56

All Insider Trades

Institutional Holders

% Shares Owned: 3.30%
# of Holders: 11
Total Shares Held: 672,587
3 Mo. Net Change: -415,778
# New Positions: 6
# Closed Positions: 3
# Increased Positions: 8
# Reduced Positions: 4
# Net Buyers: 4

Officers & Directors

Name Age Since Current Position

Ray Prudo

2017 Chairman of the Board

David Solomon

58 2017 Chief Executive Officer

Dov Elefant

2012 Chief Financial Officer

Clive Richardson

2015 Chief Operating Officer, Director

Nigel Hernandez

2017 Vice President - Worldwide Regulatory Affairs

David Byrne

2016 Director

Peter Feldschreiber

2018 Director

Michael Grissinger

2018 Director

Robert Ward

61 2016 Director

Donald Williams

60 2016 Director

James Hill

2015 Non-Executive Director

Stuart Ungar

2015 Non-Executive Director